Metabolic Disorders and their Influence on Renal Health in Diabetic Patients

Robet Wiles^*
*Correspondence: Robet Wiles, Department of Medicine & Advanced Technology, Humboldt University of Berlin, Berlin, Germany, Email:

Introduction

In recent decades, lifestyle changes and shifts in eating habits have contributed significantly to the rise in obesity rates worldwide, with a simultaneous increase in the prevalence of diabetes. The global burden of diabetes continues to grow, and as of 2020, the total number of diabetes patients reached concerning levels. In South Korea, for instance, the national prevalence of diabetes was estimated at 10.7%, with only 24.1% of patients achieving the recommended glycemic control target (HbA1c level of 6.5). South Korea also ranks third in the world in diabetes-related mortality, trailing only Mexico and Turkey, making diabetes management a national priority. Furthermore, diabetic complications are widespread, with 28.6% of patients suffering from macrovascular diseases like Cardiovascular Disease (CVD) and Peripheral Arterial Disease (PAD), and 67.2% experiencing microvascular complications such as retinopathy, nephropathy, and neuropathy. Among these complications, Diabetic Kidney Disease (DKD) stands out as one of the most severe and prevalent consequences of uncontrolled diabetes, leading to end-stage renal failure and contributing significantly to the mortality rate associated with diabetes [1].

Diabetic kidney disease is closely associated with the progression of both type 1 and type 2 diabetes. However, unlike patients with type 1 diabetes, individuals with type 2 diabetes who exhibit renal dysfunction may not show typical markers such as albuminuria. Their estimated Glomerular Filtration Rate (eGFR) may also decline for various reasons unrelated to diabetes, making early detection and management of DKD more challenging. Several risk factors contribute to the development of DKD, including hypertension, hyperglycemia, insulin resistance, oxidative stress, and the accumulation of Advanced Glycation End products (AGEs). Metabolic syndrome, which is commonly associated with obesity, insulin resistance, and hyperglycemia, plays a critical role in the pathogenesis of type 2 diabetes and significantly increases the risk of diabetes-related complications, including DKD. Understanding the relationship between metabolic syndrome, type 2 diabetes, and DKD is essential for improving patient outcomes and implementing effective interventions [2].

Description

The kidneys are vital organs responsible for filtering waste products from the blood, regulating fluid and electrolyte balance, maintaining blood pressure, and producing hormones that affect red blood cell production. However, prolonged exposure to elevated blood glucose levels due to poorly controlled diabetes can damage the blood vessels in the kidneys. This damage can lead to diabetic nephropathy, a common complication that causes the kidneys' small blood vessels to leak protein into the urine. Over time, this condition can progress, leading to kidney scarring and eventually kidney failure. Diabetic nephropathy is one of the most common causes of End-Stage Renal Disease (ESRD) in diabetic patients, and it is responsible for a significant portion of diabetes-related morbidity and mortality.

Early detection and intervention are essential in preventing the progression of diabetic nephropathy. Routine monitoring of renal function is critical, as it allows for the identification of potential kidney damage before it reaches the point of irreversible failure. Several diagnostic tests are used to assess kidney function in diabetic patients, including urine albumin-to-creatinine ratio (UACR), eGFR, and serum creatinine levels. These tests help clinicians detect early signs of kidney damage and provide insight into the stage of nephropathy. In addition, the measurement of advanced glycation end products (AGEs), which accumulate in the body as a result of chronic hyperglycemia, has shown promise as a potential marker for the progression of diabetic nephropathy. AGEs contribute to the thickening and stiffening of the glomerular basement membrane, which exacerbates kidney damage. Research has suggested that elevated AGE levels may be associated with an increased risk of renal dysfunction in patients with diabetes.

Managing blood glucose levels is the cornerstone of preventing or slowing the progression of diabetic nephropathy. Tight glycemic control, achieved through lifestyle modifications and pharmacological interventions, can significantly reduce the risk of kidney damage. Lifestyle changes, such as regular physical activity, weight management, and dietary adjustments, are crucial for controlling blood glucose levels and maintaining overall health. Pharmacological treatment options include insulin therapy and oral hypoglycemic agents, which help regulate blood sugar levels and improve insulin sensitivity. Early intervention with these therapies has been shown to reduce the risk of developing diabetic nephropathy or slow its progression in patients with existing kidney damage.

In addition to managing blood glucose levels, controlling blood pressure is essential for preventing or slowing the progression of diabetic nephropathy. Hypertension is a common comorbidity in diabetic patients and is one of the key risk factors for the development of DKD. Studies have demonstrated that maintaining blood pressure within the recommended range (below 130/80 mmHg) can significantly reduce the risk of kidney damage and improve outcomes in patients with diabetes. Antihypertensive medications, particularly angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), have been shown to be effective in reducing proteinuria and protecting kidney function in diabetic nephropathy patients. These medications help relax blood vessels, reduce blood pressure, and mitigate the damaging effects of high blood pressure on the kidneys.

Conclusion

In conclusion, diabetes, particularly type 2 diabetes, is closely linked to the development of diabetic kidney disease, a serious complication that can lead to end-stage renal failure. Metabolic syndrome, characterized by obesity, insulin resistance, and hyperglycemia, plays a significant role in the pathogenesis of both type 2 diabetes and diabetic nephropathy. Early detection and management of diabetic nephropathy are crucial for preventing the progression of kidney damage and preserving renal function. Tight glycemic control, blood pressure management, and the use of medications to address dyslipidemia and oxidative stress are key strategies for preventing or slowing the progression of diabetic nephropathy. By improving the understanding and management of metabolic illnesses, healthcare providers can reduce the risk of renal complications and enhance the quality of life for patients with diabetes.

Acknowledgement

None.

Conflict of Interest

There is no conflict of interest by author.

References

1. Obermayr, Rudolf P., Christian Temml, Maarten Knechtelsdorfer and Georg Gutjahr, et al. "Predictors of new-onset decline in kidney function in a general middle-european population." Nephrol Dial Transplant 23 (2008): 1265-1273.

Google Scholar, Crossref, Indexed at

2. Roshanravan, Baback, Cassianne Robinson-Cohen, Kushang V. Patel and Ernest Ayers, et al. "Association between physical performance and all-cause mortality in CKD." J Am Soc Nephrol 24 (2013): 822-830.

Google Scholar, Crossref, Indexed at